Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quantitative myocardial perfusion response to adenosine and regadenoson in suspected coronary artery disease
2013-001225-11Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- May 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of adenosine in coronary arteriosclerosis (2 arms), sponsored by Turku University Hospital. Started May 2013; status: completed.
02
Drugs
adenosine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2013-001225-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001225-11.